These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33311476)

  • 1. Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy.
    Brumberg J; Schröter N; Blazhenets G; Frings L; Volkmann J; Lapa C; Jost WH; Isaias IU; Meyer PT
    NPJ Parkinsons Dis; 2020 Dec; 6(1):39. PubMed ID: 33311476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
    Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
    Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal Protocol and Clinical Usefulness of
    Chun IK
    Nucl Med Mol Imaging; 2023 Jun; 57(3):145-154. PubMed ID: 37187951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
    Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
    J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of FDG-PET in the differential diagnosis of Parkinsonism.
    Brajkovic L; Kostic V; Sobic-Saranovic D; Stefanova E; Jecmenica-Lukic M; Jesic A; Stojiljkovic M; Odalovic S; Gallivanone F; Castiglioni I; Radovic B; Trajkovic G; Artiko V
    Neurol Res; 2017 Aug; 39(8):675-684. PubMed ID: 28378615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
    Sakuramoto H; Fujita H; Suzuki K; Matsubara T; Watanabe Y; Hamaguchi M; Hirata K
    Clin Park Relat Disord; 2020; 2():20-24. PubMed ID: 34316615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
    Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
    Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Catalan M; Dore F; Polverino P; Bertolotti C; Sartori A; Antonutti L; Cucca A; Furlanis G; Capitanio S; Manganotti P
    Mov Disord Clin Pract; 2021 Jul; 8(5):717-724. PubMed ID: 34295947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features.
    Uchiyama Y; Momose M; Kondo C; Kusakabe K; Uchiyama S
    Ann Nucl Med; 2011 Aug; 25(7):478-85. PubMed ID: 21499991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.
    Gabilondo I; Llorens V; Rodriguez T; Fernández M; Concha TP; Acera M; Tijero B; Murueta-Goyena A; Del Pino R; Cortés J; Gómez-Esteban JC
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):376-384. PubMed ID: 30324423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis.
    Orimo S; Suzuki M; Inaba A; Mizusawa H
    Parkinsonism Relat Disord; 2012 Jun; 18(5):494-500. PubMed ID: 22321865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET in the differential diagnosis of parkinsonian disorders.
    Eckert T; Barnes A; Dhawan V; Frucht S; Gordon MF; Feigin AS; Eidelberg D
    Neuroimage; 2005 Jul; 26(3):912-21. PubMed ID: 15955501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
    King AE; Mintz J; Royall DR
    Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIBG myocardial scintigraphy in progressive supranuclear palsy.
    Kamada T; Miura S; Kida H; Irie KI; Yamanishi Y; Hoshino T; Taniwaki T
    J Neurol Sci; 2019 Jan; 396():3-7. PubMed ID: 30391822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes.
    Garraux G; Phillips C; Schrouff J; Kreisler A; Lemaire C; Degueldre C; Delcour C; Hustinx R; Luxen A; Destée A; Salmon E
    Neuroimage Clin; 2013; 2():883-93. PubMed ID: 24179839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    Juh R; Kim J; Moon D; Choe B; Suh T
    Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of cerebral [
    Houssein NJ; Henriksen AC; Hejl AM; Marner L
    EJNMMI Res; 2023 Aug; 13(1):74. PubMed ID: 37572162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake Index of
    Kamiya Y; Ota S; Okumiya S; Yamashita K; Takaki A; Ito S
    Asia Ocean J Nucl Med Biol; 2017; 5(1):37-43. PubMed ID: 28840137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia.
    Walker Z; Gandolfo F; Orini S; Garibotto V; Agosta F; Arbizu J; Bouwman F; Drzezga A; Nestor P; Boccardi M; Altomare D; Festari C; Nobili F;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1534-1545. PubMed ID: 29779045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.